Phospholipid transfer protein

Current Opinion in Lipidology

Volumn 13, Issue 2, 2002, Pages 135-139

  Van Tol, Arie ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; PHOSPHOLIPID TRANSFER PROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPOPROTEIN BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PHOSPHOLIPID TRANSFER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; ARTERIOSCLEROSIS; CARRIER PROTEINS; CHOLESTEROL; HUMANS; LIPOPROTEINS, HDL; LIPOPROTEINS, VLDL; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHOLIPID TRANSFER PROTEINS;

MUS MUSCULUS;

EID: 0036217558     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-200204000-00004     Document Type: Review

References (38)

1. Targeted mutation of plasma phospholipid transfer protein gene markedly reduces high-density lipoprotein levels
2. Remodelling of high density lipoproteins by plasma factors
3. The impact of phospholipid transfer protein (PLTP) on HDL metabolism
4. Cellular cholesterol efflux
5. 1999 Georg Lyman Duff Memorial Lecture: Lipid transfer proteins, HDL metabolism and atherogenesis
6. Phospholipid transfer protein in lipid metabolism
7. Molecular biology of phospholipid transfer protein
8. Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues
9. Lipid transfer protein activities in type 1 diabetic patients without renal failure and non-diabetic control subjects and their association with coronary artery calcification
10. Quantification of human plasma phospholipid transfer protein (PLTP): Relationship between PLTP mass and phospholipid transfer activity
11. Measurement of human plasma phospholipid transfer protein by sandwich ELISA
12. Distribution of phospholipid transfer protein in human plasma: Presence of two forms of phospholipid transfer protein, one catalytically active and the other inactive
13. Phospholipid transfer is a prerequisite for PLTP-mediated HDL conversion
14. A hydrophobic cluster at the surface of the human plasma phospholipid transfer protein is critical for activity on high density lipoproteins
15. Mechanism of the phospholipid transfer protein-mediated transfer of phospholipids from model lipid vesicles to high density lipoproteins
16. The mechanism of the remodelling of high density lipoproteins by phospholipid transfer protein
17. Acute-phase HDL in phospholipid transfer protein (PLTP)-mediated HDL conversion
18. Human plasma phospholipid transfer protein increases the antiatherogenic potential of high density lipoproteins in transgenic mice
19. Dynamic changes in mouse lipoproteins induced by transiently expressed human phospholipid transfer protein (PLTP): Importance of PLTP in prebeta-HDL generation
20. Evaluation of phospholipid transfer protein and cholesteryl ester transfer protein as contributors to the generation of preβ-high-density lipoproteins
21. Cholesteryl ester transfer protein and phospholipid transfer protein have nonoverlapping functions in vivo
22. Phospholipid transfer protein gene knock-out mice have low high density lipoprotein levels, due to hypercatabolism, and accumulate apoA-IV-rich lamellar lipoproteins
23. Apolipoprotein B secretion and atherosclerosis are decreased in mice with phospholipid-transfer protein deficiency
24. Phospholipid transfer protein increases VLDL secretion in transgenic mice
25. Plasma phospholipid transfer protein activity is related to insulin resistance: Impaired acute lowering by insulin in obese Type II diabetic patients
26. Plasma phospholipid transfer protein activity is lowered by 24-h insulin and acipimox administration: Blunted response to insulin in type 2 diabetic patients
27. Influence of obesity and insulin sensitivity on phospholipid transfer protein activity
28. Mass concentration of plasma phospholipid transfer protein in normolipidemic, type IIA hyperlipidemic, type IIB hyperlipidemic, and non-insulin-dependent diabetic subjects as measured by a specific ELISA
29. Twenty four hour insulin infusion impairs the ability of plasma from healthy subjects and Type 2 diabetic patients to promote cellular cholesterol efflux
30. Short-term Acipimox decreases the ability of plasma from Type 2 diabetic patients and healthy subjects to stimulate cellular cholesterol efflux: A potentially adverse effect on reverse cholesterol transport
31. Role of phospholipid transfer protein and prebeta-high density lipoproteins in maintaining cholesterol efflux from Fu5AH cells to plasma from insulin-resistant subjects
32. Plasma phospholipid transfer protein activity in patients with low HDL and cardiovascular disease treated with simvastatin and niacin
33. Functional analysis of the transcriptional activity of the mouse phospholipid transfer protein gene
34. Glucose regulates the transcription of human genes relevant to HDL metabolism: Responsive elements for peroxisome proliferator-activated receptor are involved in the regulation of phospholipid transfer protein
35. Induction of the phospholipid transfer protein gene accounts for the high density lipoprotein enlargement in mice treated with fenofibrate
36. The farnesoid X-activated receptor mediates bile acid activation of phospholipid transfer protein gene expression
37. The cholesterol-raising diterpenes from coffee beans increase serum lipid transfer protein activity levels in humans
38. Consumption of French-press coffee raises cholesteryl ester transfer protein activity levels before LDL cholesterol in normolipidaemic subjects